Johnson & Johnson (NYSE:JNJ) - Page 2

As Recession Fears Grow, 15 Stocks to Survive a Stock Market Correction

Friday brought on major selling in the stock market, with the Dow Jones industrials down over 400 points and the S&P 500 down almost 50 points earlier in the ...
Read Full Story »

How Much More Talc Fallout Will Johnson & Johnson Face After This $29 Million Verdict?

A California jury has awarded $29 million to a woman who claimed talcum-powder-based Johnson & Johnson (NYSE: JNJ) products caused her cancer. This ruling is the most recent defeat, out of ...
Read Full Story »

10 Companies That Have Raised Their Dividends for 50 Consecutive Years

It's no secret that investors love dividends. It is also no secret that dividends make a sizable contribution to investors' total returns over time. What they really love is when ...
Read Full Story »

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Golden crosses and death crosses are common signals in technical analysis and refer to the relationship between short-term and long-term moving averages. The golden cross typically is seen as a ...
Read Full Story »

Johnson & Johnson Faces More Overhang From Talc and Asbestos Woes

Johnson & Johnson (NYSE: JNJ) remains a top member of the Dow Jones industrial average and a company that keeps raising its dividend year after year. And the company still ...
Read Full Story »

Huge Johnson & Johnson Acquisition Targets Robotics

On Wednesday, Johnson & Johnson (NYSE: JNJ) announced that its subsidiary, Ethicon, had entered a definitive agreement to acquire Auris Health, a robotic technology firm, initially focused on lung cancer. Management ...
Read Full Story »

The 15 Best Dividend Stocks for Retirees to Own

There are many types of investors in America. Whether you are in your twenties or retired, it is important to know what strategy is the best fit for your portfolio. ...
Read Full Story »

How the 30 Dow Stocks Are Doing in 2019

As 2019 unfolds, one question is likely on most investors’ minds: Is the bull market that began in March 2009 dead, or can it find its footing on less stable ...
Read Full Story »

Johnson & Johnson Earnings: When Good Enough Just Isn’t Good Enough

Johnson & Johnson (NYSE: JNJ) released its fourth-quarter financial results before the markets opened on Tuesday. The health care giant said that it had in $1.97 earnings per share (EPS) ...
Read Full Story »

7 of This Week’s Most-Anticipated Earnings Reports

Now that the fourth-quarter earnings reporting season has kicked off, many major companies will be sharing their results in the coming weeks. Here, 24/7 Wall St. has put together a ...
Read Full Story »

Boeing and J&J Both Offer New Incentives for Investors After Big Losses

Two members of the thirty Dow Jones industrial average index have been under siege and are now fighting back. Whether the news will last or be forgotten going into 2019 ...
Read Full Story »

Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder

Reuters reported on Friday that Johnson & Johnson (NYSE: JNJ) knew for decades that its baby powder sometimes contained the known carcinogen asbestos. According to the report, the pharmaceutical and health ...
Read Full Story »

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019 rather than looking back at how choppy 2018 has been. ...
Read Full Story »

After the Midterm Elections, 10 Defensive Stocks to Buy for 2019

The political pollsters actually got it right this time. The Republican party kept the Senate, but the Democrats took back control of the House of Representatives in the 2018 midterm ...
Read Full Story »

Should Johnson & Johnson Be Getting More Out of Q3 Earnings?

Johnson & Johnson (NYSE: JNJ) reported its third-quarter financial results before the markets opened on Thursday. The company said that it had $2.05 in earnings per share (EPS) and $20.35 ...
Read Full Story »